Covid Vaccinations May Start December: Vanderbilt's Schaffner

The transcript discusses the promising effectiveness of a new vaccine, highlighting its 90% success rate. It addresses uncertainties about its impact on older populations and severe disease prevention. The production capacity is limited, covering only 650 million people by 2021. The vaccine requires two doses, with potential side effects. Public hesitancy is noted, with half the population waiting to see initial results. Logistical challenges include maintaining cold storage and training for proper administration. Other vaccines are in development, offering hope for broader solutions.

What was the effectiveness percentage mentioned for the vaccine discussed?

How does the vaccine's effectiveness in older persons remain uncertain?

What is the significance of the two-dose requirement for the vaccine?

What are the anticipated challenges in getting people vaccinated?

What logistical issues must companies like Pfizer address for vaccine distribution?